RAGOSA MARK (Interim CFO) exercised options at KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 4/8/2026ACC: 0001835458-26-000010
Officer· Interim CFO
Since Dec 2020
-1.30K
Net shares
Net seller
$63.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
2.69K acquired · 4K disposed
Non-Derivative Transactions2
Class A Ordinary Share
Direct
Shares
+2.69K
Price / share
—
Trade value
—
% of position
18.2%
4/7/2026
14.76K→17.46K
Class A Ordinary Share
Direct
Shares
−1.30K
Price / share
$48.94
Trade value
$63.77K
% of position
7.5%
4/7/2026
17.46K→16.15K
Total
Net shares
+1.39K
Net value
-$63.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share Direct | 4/7/2026 | M · Option Exercise | +2.69K | — | — | 18.2% | 14.76K | 17.46K |
| Class A Ordinary Share Direct | 4/7/2026 | F · Tax Withholding | −1.30K | $48.94 | $63.77K | 7.5% | 17.46K | 16.15K |
| Total | +1.39K | -$63.77K | ||||||
Derivative Transactions1
Restricted Share Unit
Direct
Converts to
Class A Ordinary Share
2.69K shares
Shares
−2.69K
Strike price
Held after
0.00
Exercisable
—
4/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Unit Direct | Class A Ordinary Share2.69K shares | 4/7/2026 | M · Option Exercise | −2.69K | — | 0.00 |